Find your path to Yann
295 people in our graph share verified history with Yann — schools, employers, funds. One of them is your warm intro.
Anika GuptaunlockedYann: together at Flagship Pioneering (2018)
×5Yann: together at Flagship Pioneering
Yann: together at Tg Therapeutics
×3Yann: together at Genzyme Transgenics Corporation
About
Yann Echelard is President at ORI Capital, a firm that invests in healthcare companies globally. He was previously an Operating Partner at Flagship Pioneering, where he focused on launching internally-generated platform companies. His background in the biotechnology industry spans research and development, clinical development, quality and GMP manufacturing, corporate and business development, and commercial activities.
Experience
- ORI CapitalPresidentcurrent2026 — presentBoston, Massachusetts, United States
- TG TherapeuticsMember Board of Directorscurrent2012 — present
- Flagship PioneeringOperating Partner2018 — 2026Cambridge, MA
- LFBExecutive Committee Member2015 — 2018Greater Paris Metropolitan Region
- HEMA BiologicsMember Board of Directors2015 — 2018
- LFB USAMember Board of Directors2014 — 2018Framingham, MA USA
- rEVO BiologicsPresident, CEO and Board Member2014 — 2018Framingham, MA USA
- rEVO BiologicsPresident2013 — 2018Framingham, Massachusetts
- GTC BiotherapeuticsPresident2012 — 2013
- GTC BiotherapeuticsVP Corporate and Technology Development2010 — 2012
- GTC BiotherapeuticsVP Research and Development2002 — 2010
- Genzyme Transgenics CorporationDirector of Embryology1998 — 2002
- Genzyme Transgenics CorporationScientist1994 — 1998
- Harvard University, Dept of Molecular and Cellular BiologyPostdoctoral Fellow1993
- Roche Institute of Molecular BiologyVisiting Scientist1991 — 1993
- Ludwig Institute for Cancer Research, Montreal BranchPostdoctoral Fellow1989 — 1991
Skills & more
Leadership1Problem SolvingStrategic PlanningProduct Development1Board Governance1Biotechnology25Lifesciences13Biopharmaceuticals28FDA12Laboratory7Technology Transfer12Commercialization8
+12 more
Drug DiscoveryClinical DevelopmentDrug DevelopmentGMPValidationImmunologyR&DVaccinesMolecular BiologyOncologyMedical DevicesPharmaceutical IndustryLanguages English · French · Spanish
From Yann's professional profile.
Colleagues at ORI Capital
Alexander Li
Investment Analyst at ORI Capital
Arnold Ching
Investment Associate at ORI Capital
Becky Chan
Approach-specific Scientist, PhD at ORI Capital
Ben Kong
Approach-specific Scientist, PhD at ORI Capital
Cathy Choi
Financial Controller at ORI Capital
Dicky To
Partner at ORI Capital
Elaine Yang
Director at ORI Capital
Gang Song
Operating Partner, PhD at ORI Capital
Frequently asked questions
- Who is Yann Echelard?
- Yann Echelard is President at ORI Capital, a firm that invests in healthcare companies globally. He was previously an Operating Partner at Flagship Pioneering, where he focused on launching internally-generated platform companies. His background in the biotechnology industry spans research and development, clinical development, quality and GMP manufacturing, corporate and business development, and commercial activities.
- Where does Yann Echelard work?
- Yann Echelard is Partner at ORI Capital.
- Where did Yann Echelard go to school?
- Yann Echelard studied at Université de Montréal (PhD, Microbiologie et Immunologie).
Same school
Also attended Université de Montréal97
Anne-Sophie GauvinCommunications & Office Manager at Luge CapitalJyri EngeströmPartner at Lifeline VenturesRajaa GrarVenture Partner at Springdale VenturesErich SieberFounding General Partner at PeakBridge VCHenri ArslanianMember of Advisory Board at Hex TrustFrancois GrattonInvestor at AgeTech Capital
+ 91 more
Shared employers
Also worked at TG Therapeutics3
Also worked at Flagship Pioneering105
Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringCassidy BlundellPartner at Mission BiocapitalDavid KoleskyPrincipal at MPM BioImpactDiana BernsteinDirector at Northpond VenturesInca ComanVenture Partner at ARCH Venture Partners
+ 99 more
Also worked at LFB1
Also worked at Genzyme Transgenics Corporation243
Steve LiapisManaging Director at Northpond VenturesWalter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesSun AltbachSenior Scientific Advisor at BOLD LongevityMatt VineSenior Associate at RRE Ventures
+ 237 more






























)


